help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trempus, C. S.
Right arrow Articles by Mahler, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trempus, C. S.
Right arrow Articles by Mahler, J. F.
(American Journal of Pathology. 1998;153:247-254.)
© 1998 American Society for Investigative Pathology

Regular Articles

Association of v-Ha-ras Transgene Expression with Development of Erythroleukemia in Tg.AC Transgenic Mice

Carol S. Trempus* , Sandra Ward{dagger} , Georgia Farris{ddagger} , David Malarkey{dagger} , Randall S. Faircloth* , Ronald E. Cannon* and Joel F. Mahler{dagger}

From the Laboratory of Environmental Carcinogenesis and Mutagenesis* and the Laboratory of Experimental Pathology,{dagger} National Institute of Environmental Health Sciences, and the Chemical Industrial Institute of Toxicology,{ddagger} Research Triangle Park, North Carolina

A transgenic mouse line (Tg.AC) carrying an activated v-Ha-ras oncogene fused to the embryonic {zeta}-globin promoter develops an array of spontaneous epithelial and mesenchymal neoplasms. In this report we describe the morphological, immunophenotypic, and molecular features of a unique hematopoietic neoplasm in these mice. The cardinal lesion of this disease is marked hepatomegaly due to leukemic proliferation and infiltration. In the peripheral blood, there is a marked increase in the number of metarubricytes and other less differentiated erythroid progenitor cells. Leukemic cells stain positively with an erythroid-associated nuclear transcription factor (GATA-1). Using a reverse transcription polymerase chain reaction assay, co-expression of GATA-1 and endogenous {zeta}-globin genes is detected in hematopoietic tissues of nonleukemic transgenic and nontransgenic mice. ras transgene expression is, however, detected only in normal bone marrow and leukemic tissues of transgenic mice, and 5' mapping experiments using S1 protection analysis of total RNA from leukemic tissue indicates that transcription of the transgene mRNA is initiated from the natural {zeta}-globin promoter start site, supporting the belief that the {zeta}-globin promoter directs v-Ha-ras expression in erythroid progenitor cells, ultimately leading to leukemic transformation.




This article has been cited by other articles:


Home page
 Toxicol SciHome page
K. L. Thompson and F. D. Sistare
Selection of Drugs to Test the Specificity of the Tg.AC Assay by Screening for Induction of the gadd153 Promoter in Vitro
Toxicol. Sci., August 1, 2003; 74(2): 260 - 270.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K. R. Martin, C. Trempus, M. Saulnier, F. W. Kari, J.C. Barrett, and J. E. French
Dietary N-acetyl-L-cysteine modulates benzo[a]pyrene-induced skin tumors in cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) mice
Carcinogenesis, September 1, 2001; 22(9): 1373 - 1378.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
L. N. Healy, L. J. Pluta, R.A. James, D. B. Janszen, D. Torous, J. E. French, and L. Recio
Induction and time-dependent accumulation of micronuclei in peripheral blood of transgenic p53+/- mice, Tg.AC (v-Ha-ras) and parental wild-type (C57BL/6 and FVB/N) mice exposed to benzene by inhalation
Mutagenesis, March 1, 2001; 16(2): 163 - 168.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Society for Investigative Pathology.